Materials and Methods
Of the patients who underwent TKA for unilateral/bilateral osteoarthritis of the knee at our institution between March 2012 and January 2013, 97 TKA patients (64 unilateral and 33 bilateral) were included in this retrospective surgery. The exclusion criteria were ≥80 years of age, a previous history of arterial occlusion such as myocardial infarction and cerebral infarction or of venous occlusion such as deep vein thrombosis (DVT), preoperative hemoglobin (Hb) level of 10 g/dL or less, blood coagulation dysfunction, renal failure, a recent or previous seizure that precludes the use of tranexamic acid. In the experimental group, there were 46 TKA patients: 29 unilateral patients were classified into group I and 17 bilateral patients into group III. All the patients in the experimental group underwent intravenous injection of tranexamic acid during surgery and neutral drainage for three postoperative hours. The control group consisted of 51 patients: 35 unilateral patients were categorized into group II and the 16 bilateral patients into group IV. These patients underwent negative pressure drainage immediately postoperatively without the use of tranexamic acid.
The surgery was performed using the subvastus approach with a tourniquet pressure of 300 mmHg. An intramedullary guide was used for femoral and tibial alignment. The femoral intramedullary hole was filled with a piece of cortical bone obtained intraoperatively. Bone cement was used for fixation of the femur and tibia. In the experimental group, single intravenous injection of 10 mg/kg tranexamic acid was performed 30 minutes prior to the tourniquet was released following suture closure. For three postoperative hours, neutral drainage was maintained in groups I and III, and then negative pressure was applied. In groups II and IV, negative pressure drainage was utilized immediately postoperatively. In all four groups, drainage was removed based on the drainage volume assessed for two postoperative days.
For seven postoperative days, fondaparinux (Arixtra Injection; GlaxoSmithKline, Brentford, UK) was given for DVT prophylaxis. Postoperative development of DVT was examined by sonography among patients who presented with lower limb pain. Active straight leg raising exercises and knee exercises were initiated from the day of surgery and partial weight bearing was recommended. Blood transfusion was performed under the following conditions: if the Hb level was 8 mg/dL, a 320 mL of packed red blood cell was transfused for a Hb of 1 mg/dL and even if the Hb level was ≥8 mg/dL, transfusion was performed in the presence of anemic symptoms such as tachycardia. In all patients, body mass index (BMI), prothrombin time (PT), and activated partial thromboplastin time (aPTT) were assessed preoperatively. The Hb level and hematocrit were evaluated preoperatively and until the forth postoperative day. Postoperatively, the volume of blood loss was measured according to the methods of Nadler et al. 10) and Sehat et al. 11) . In addition, the frequency and volume of blood transfusion were assessed. 10) .
Blood loss was calcuated with use of the Sehat's fomula 11) .
Statistical analysis was performed using PASW ver. 21.0 (SPSS Inc., Chicago, IL, USA). T-test was used for comparison of groups with a level of statistical significance set at p<0.05.
results
There was no significant intergroup difference with regard to the preoperative BMI, PT, and aPTT ( Table 1 ). The mean reduction in Hb level on the 4th postoperative day was 3.34±1.65 g/dL in group I, 3.60±1.07 g/dL in group II, 3.91±1.20 g/dL in group III, and 3.91±1.57 g/dL in group IV. Although the reduction was significantly greater in group II than group I on the 1st postoperative day (p=0.036), no statistically significant difference was noted in other comparisons (Tables 2 and 3) .
The drainage volume assessed on the 1st postoperative day and 2nd postoperative day was 339.1±171.4 mL and 117.5±92.9 mL, respectively, in group I and 494.0±198.3 mL and 186.0±72.0 mL, respectively, in group II. The combined total drainage volume until the 2nd postoperative day was significantly smaller in group I (p<0.05). The values were smaller in group III with 591.9±241.1 mL and 287.4±225.5 mL, respectively, than group IV with 950.0±362.6 mL and 330.3±176.0 mL, respectively. The differences between group III and group IV were statistically significant regarding the drainage volume assessed on the 1st postoperative and the total combined drainage volume until the 2nd postoperative day (p<0.05). The blood loss volume was not significantly different between group I and group II although the value was 12% smaller in group I (1,147.9±485.5 mL) than group
Kim et al. Blood Loss with or without Transexamic Acid and Negative Drainage after TKA
II (1,292.6±512.2 mL). Between group III and group IV, the value was 35% smaller in group III than group IV (1,329.0±377.0 mL vs. 2,043.2±1,143.3 mL), indicating statistical significance (p= 0.029). The frequency of transfusion was lower in group I (10.3%) than group II (17.1%), but the difference was not statistically significant (p=0.436), whereas the value was significantly lower in group III (5.9%) than group IV (43.8%) (p=0.011). The mean transfusion volume was less in group I (55.2±172.5 mL) than group II (122.4±294.9 mL), but the difference was not significant (p=0.285), whereas the value was significantly smaller in group III (37.6±155.2 mL) than group IV (480.0±650.5 mL) (p=0.017) ( Tables 2 and 3) .
discussion
Knees surgeons have increased efforts to reduce complications associated with massive blood loss after TKA. Among various methods, tranexamic acid injection and drainage are most preferred and recent reports have documented successful outcomes of the method. In this study, we retrospectively investigated the influence of the combined use of tranexamic acid and drainage on blood loss: among bilateral TKA patients, the method resulted in statistically significantly less drainage volume, transfusion frequency, transfusion volume, and blood loss. TKA offers satisfying treatment results, but it has been associated with massive blood loss compared to other orthopedic operations. Lotke et al. 12) reported a mean blood loss of 1,518 mL in their TKA patients, indicating the increased necessity of blood transfusion after TKA. Resection of the bone or soft tissue during TKA can result in blood loss from the cut surface. Besides such 'visible' blood loss, hidden blood loss due to bleeding into the soft tissue, despite not negligible in terms of the amount, can cause underestimation of the total amount of blood loss. Sehat et al. 11, 13) calculated the amount of blood loss using Hct. In their study, the mean postoperative blood loss was 1,498 mL, and approximately 735 mL (49%) of which was hidden blood loss. In our study, in order to assess the exact amount of blood loss, we calculated the preoperative total blood volume according to the patient's height, weight, and gender using the Nadler's formula 10) and measured the amount of blood loss according to the change in Hct between the preoperative and postoperative assessments as suggested by Sehat et al. 11) . Blood transfusion can be required after TKA. Studies have reported the frequency of transfusion after unilateral TKA as 4%-46% and that after bilateral TKA as 31%-72% [14] [15] [16] [17] [18] . Allogeneic blood transfusion is the most common form of transfusion performed after TKA. However, it carries inherent risks such as transmission of infectious diseases. Dodd 19) documented the risk of human immunodeficiency virus transmission as 1/225,000 per unit of transfusion, hepatitis B virus transmission as 1/200,000, hepatitis C virus transmission as 1/30,000-1/150,000, and human T-cell lymphotropic virus transmission as 1/50,000. In addition, some studies have reported that allogeneic transfusion increases the risk of postoperative infection compared to autologous transfusion or no use of transfusion. In a study by Rosencher et al. 3) , postoperative infection rate was lower in the autologous transfusion group than the allogeneic transfusion group (1% vs. 4%) in patients with knee and hip arthroplasty. Friedman et al.
2) compared the infection rates between the allogeneic transfusion group and the no transfusion/autologous transfusion group following total hip arthroplasty or TKA: the rate of upper/ lower respiratory tract infection and the rate of wound inflammation/infection at the surgical site were significantly higher in the former group (2.1% and 2.4%, respectively) than the latter group (1.7% and 1.7%, respectively). Hart et al. 20) found that the incidence of mortality significantly increased in patients with allogeneic transfusion than those without blood transfusion after unilateral TKA. Newman et al. 21) reported that the rate of revision due to suspicion of infection within 3 postoperative months was significantly higher in patients with allogeneic transfusion (1.67%) than those with autologous transfusion (0.66%) or without transfusion (0.75%). Such complications of allogeneic transfusion have recently prompted many surgeons to attempt other techniques to reduce blood loss in TKA patients.
In particular, tranexamic acid administration is widely accepted by surgeons as a strategy for blood loss reduction. Tranexamic acid is a synthetic antifibrinolytic agent that reversibly binds to lysine union sites of the plasmin and plasminogen 22) . One of the reported adverse effects of tranexamic acid is blood clot formation that can lead to DVT, pulmonary embolism, and cerebral infarction; however, the incidences of such side effects were not statistically significantly high in many studies 5, 23, 24) . In the current study, complications such as DVT were not found to have developed in sonography among patients who received tranexamic acid and complained lower limb pain. Tranexamic acid can be administered intravenously, intra-articularly, or orally. The optimal administration method and dosage and efficacy of tranexamic acid have yet to be established. Maniar et al. 5) compared groups that underwent intravenous injection of tranexamic acid preoperatively, intraoperatively, and 1-3 times postoperatively and the group that received a single local injection. Their finding was that blood loss/drainage volume could be significantly reduced by more than 2 injections or a local injection. Charoencholvanich and Siriwattanasakul 4) reported that intravenous injection before surgery, 10 minutes before tourniquet deflation, and three hours after surgery combined with 5 days of oral administration was remarkably effective in decreasing postoperative drainage volume, Hb level, frequency of transfusion, and transfused volume without any side effects. Tanaka et al. 7) reported that 1-2 times of intravenous injection of tranexamic acid before surgery and on tourniquet deflation resulted in significant reduction in blood loss and transfusion volume without the risk of complications compared to the group without the use of tranexamic acid. In a study by Orpen et al. 6) , one intravenous injection of tranexamic acid given 10 minutes prior to tourniquet deflation was effective in reducing blood loss in the early postoperative period. Benoni et al. 25) reported that the maximum blood concentration was achieved within 5-15 minutes after intravenous injection of tranexamic acid. In the current study, we performed one intravenous injection of 10 mg/kg tranexamic acid 30 minutes before tourniquet release during suture closure after implant insertion. 9) reported that compared to the group where tranexamic acid was given intravenously and orally during and after surgery, the amount of blood loss, blood transfusion, and Hb level reduction were significantly smaller the group where the drain was clamped for three postoperative hours, unclamped for another 3 hours, and then reclamped for the next three hours. Aksoy et al. 8) found that two-hour postoperative drain clamping without intraoperative bleeding control resulted in no significant difference with intraoperative bleeding control without clamping. Therefore, they concluded that twohour drain clamping could be as effective as intraoperative bleeding control in terms of blood loss reduction, thereby shortening the operation time. In the current study, intraoperative administration of tranexamic acid combined with 3-hour postoperative neutral drainage resulted in a significant decrease in the volume of drainage in the unilateral and bilateral TKA patients in the experimental group than those in the control group. In addition, the amount of blood loss, transfusion frequency, and transfusion volume were remarkably smaller in the experimental group; the difference was at a statistically significantly level especially for the bilateral TKA patients in the experimental group. In this study, we observed that the experimental group that underwent intraoperative injection of tranexamic acid and neutral drainage for three hours after TKA had significantly less drainage volume, leading us to believe that the method could be helpful in reducing unexpected blood loss after surgery. On the other hand, there was no notable difference with the control group with regard to the Hb level reduction, amount of blood loss, and transfusion frequency and volume. In addition, the experimental group showed greater Hb level reduction on the 1st postoperative day. We attribute this to the higher transfusion rate in the control group than the experimental group (17% vs. 10%) on the 1st and 2nd postoperative days. In particular, bilateral TKA patients in the experimental group exhibited significantly better results than those in the control group with regard to the drainage volume, blood loss volume, and transfusion frequency and volume. Taking all these findings into account, we believe that the intraoperative injection of tranexamic acid and three postoperative hour neutral drainage method would prevent acute massive blood loss and reduce symptoms related to blood loos, thereby decreasing the frequency and volume of transfusion. Regardless of the group, there was a tendency for the Hb level to fall drastically on the 1st and 2nd postoperative days, decrease less markedly on the 3rd postoperative day, and then rather increase on the 4th postoperative day. Therefore, we suggest that blood transfusion should not be determined based only on the Hb level to avoid unnecessary transfusion, which should be investigated more thoroughly in further studies (Fig. 1) . The limitations of this study include the use of two variables (tranexamic acid and neutral drainage for three postoperative hours) and the small sample size. We think that univariate analyses using a single variable should be performed in future studies of a prospective design involving a larger study population. Furthermore, the optimal dosage of tranexamic acid should also investigated in future research.
conclusions
Administration of tranexamic acid 30 minutes prior to tourniquet deflation combined with application of neutral drainage for three postoperative hours was effective in reducing blood loss and preventing side effects of transfusion. The method would be 
